Y. Chiba

Antitumor activity of delocalized lipophilic cation, MKT-077 in human carcinomas obtained from fresh surgical specimens

T. Kubota, Y. Otani, Masahiko Watanabe, 1999, International Journal of Clinical Oncology.

Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy

T. Sugai, H. Itamochi, N. Yoshino, 2017, International Journal of Gynecologic Cancer.

A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

K. Yonemori, Masamichi Takahashi, I. Kinoshita, 2022, BMC cancer.

MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice.

T. Kubota, Y. Otani, M. Kitajima, 1998, Anticancer research.

Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.

S. Okada, M. Tezuka, Y. Chiba, 1986, Journal of pharmacobio-dynamics.

Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study

M. Kagabu, T. Shoji, E. Takatori, 2023, AntiCancer Research.

Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS

T. Sugai, H. Itamochi, Nao Oumi, 2017, Human Cell.